Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.4.2.7 (
adenine phosphoribosyltransferase
)
692
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The imprinted multimembrane-spanning polyspecific transporter-like gene 1 (
IMPT1
) encodes a predicted protein with organic cation transport capabilities. As a first step in understanding the function of
IMPT1
, we identified the renal structures expressing this gene in knockout mice with
adenine phosphoribosyltransferase
(
APRT
) deficiency and 2,8-dihydroxyadenine (DHA) nephrolithiasis.
IMPT1
mRNA was not detected using a standard in situ hybridization (ISH) protocol, but we observed intense staining in cortico-medullary tubules and glomeruli in wild-type mice using an improved reverse transcription-polymerase chain reaction (RT-PCR) ISH procedure.
IMPT1
mRNA expression was significantly decreased in the cortical region in kidney sections from
APRT
-deficient male mice.
APRT
-deficient female mice are less severely affected by DHA-induced kidney stone disease, and we observed only a modest reduction in
IMPT1
expression in kidneys from these mice.
IMPT1
expression in
APRT
heterozygous mice was comparable to that in wild-type mice, suggesting imprinting of one of the parental alleles. These findings suggest that decreased
IMPT1
mRNA expression may contribute to the impaired renal function in
APRT
-deficient male mice, and that RT-PCR ISH is a valuable tool for localizing the site of expression of transcripts that are not detectable using standard ISH procedures.
...
PMID:Impaired expression of an organic cation transporter, IMPT1, in a knockout mouse model for kidney stone disease. 1285 69